SpliceBio

Sparing Vision

This genomic medicine company develops mutation-agnostic gene therapies to preserve and restore sight for patients with blinding inherited retinal diseases.

AAVantgarde

This biotechnology company develops gene therapies for patients with inherited retinal diseases, such as Stargardt disease and Usher syndrome type 1B.

AAVantgarde Bio

AAVantgarde Bio develops proprietary viral vector platforms to deliver large genes for treating patients with inherited retinal diseases.

Ray Therapeutics

The company develops optogenetic gene therapies to restore vision for patients with blinding retinal diseases.

Spot Biosystems

This company develops non-viral gene therapy delivery platforms using extracellular vesicles to treat genetic diseases for pharmaceutical partners and healthcare providers.

RhyGaze

This biotechnology company develops optogenetic gene therapies to restore vision for patients with retinal diseases causing blindness.

Stridebio

This company develops engineered viral vectors and gene therapies for patients with rare genetic diseases.

PulseSight Therapeutics

This company develops non-viral gene therapies for patients with severe eye diseases including age-related macular degeneration.